Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sq 26900
2. Sq 26991
3. Sq-26900
4. Sq-26991
5. Zofenil
6. Zofenopril
7. Zofenopril, Calcium Salt, (1(r*),2alpha,4alpha)-isomer
8. Zofil
1. 81938-43-4
2. Zofenopril Calcium Salt
3. Zoprace
4. Zofenopril Calcium [usan]
5. Sq 26991
6. Chebi:82600
7. 81938-43-4 (calcium)
8. 88zq329pu2
9. Zofenoprilcalcium
10. Sq-26991
11. Zofenopril Calcium (usan)
12. Calcium (2s,4s)-1-((s)-3-(benzoylthio)-2-methylpropanoyl)-4-(phenylthio)pyrrolidine-2-carboxylate
13. Unii-88zq329pu2
14. Bifril-d5
15. Zoprace (tn)
16. Ncgc00182038-01
17. Dsstox_cid_28551
18. Dsstox_rid_82823
19. Dsstox_gsid_48625
20. Schembl641349
21. Chembl2105776
22. Dtxsid1048625
23. Zofenopril Calcium [mart.]
24. Zofenopril Calcium [who-dd]
25. Tox21_112966
26. Mfcd08704648
27. Zofenopril Calcium Salt [mi]
28. Akos015840019
29. Akos015967030
30. Ac-4336
31. (4s)-n-((s)-3-mercapto-2-methylpropionyl)-4-(phenylthio)-l-proline Benzoate (ester), Calcium Salt
32. As-81847
33. So 26991
34. Cas-81938-43-4
35. Zofenopril Calcium, >98% (hplc), Powder
36. Z0041
37. D03767
38. A840224
39. Q-101025
40. Q27156118
41. (4s)-n-((s)-3-mercapto-2-methylpropionyl)-4-(phenylthio)-r-proline Benzoate (ester), Calcium Salt
42. [1(s),4(s)]-1-(3-mercapto-2-methyl-1-oxopropyl)-4-phenyl-thio-l-proline-s-benzoyl Ester Calcium Salt
43. Bis[1-[(s)-3-(benzoylthio)-2-methyl-1-oxopropyl]-4alpha-(phenylthio)-l-proline] Calcium Salt
44. Calcium (2r,4r)-1-[(2s)-3-benzoylsulfanyl-2-methyl-propanoyl]-4-phenylsulfanyl-pyrrolidine-2-carboxylate
45. Calcium Bis[(2s,4s)-1-[(2s)-3-(benzoylsulfanyl)-2-methylpropanoyl]-4-(phenylsulfanyl)pyrrolidine-2-carboxylate]
46. Calcium;(2s,4s)-1-[(2s)-3-benzoylsulfanyl-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylate
47. L-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, Calcium Salt, (1(r*),2alpha,4alpha)-
48. R-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, Calcium Salt, (1(r*),2.alpha.,4.alpha.)-
Molecular Weight | 897.2 g/mol |
---|---|
Molecular Formula | C44H44CaN2O8S4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 14 |
Exact Mass | 896.1606419 g/mol |
Monoisotopic Mass | 896.1606419 g/mol |
Topological Polar Surface Area | 256 Ų |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 582 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?